Meeting Report
Understanding the immense problem related to the current opioid/opiate epidemic in America and around the world, faced with the unfortunate fact that for example, in Ohio state at least 23 people die from an overdose of heroin every week! The first conference devoted to the Reward Deficiency Syndrome (RDS) -Inaugural Reward Deficiency Syndrome Summit (RDS-1) was concluded successfully on November 18, 2015. The three-day summit chaired by Prof. Kenneth Blum and Prof. Rajendra D. Badgaiyan with the theme "Reward Deficiency Syndrome in the 21st Century: Epigenetics, Neurogenetics, Neuroimaging tools for Therapy and Recovery" was organized by United Scientific Group on November 16-18, 2015 at DoubleTree by Hilton San Francisco Airport Hotel, CA and attended by speakers and delegates from more than 10 countries. The summit witnessed 10 keynote presentations, around 30 oral presentations on various topics of addiction research and therapy, Reward Deficiency Syndrome on Dopamine and Psychiatry, Substance Abuse, Alcoholism and Neurobiology of Reward Deficiency Syndrome.
For this three day summit we have selected evidence-based scientifically sound abstracts pertaining to all aspects of addiction. These abstracts selected for presentation constitutes both animal and human studies and novel methods relevant to addiction research. Particularly, the areas covered in this conference on RDS involve genomics, epigenetics, pharmacogenomics, neuroimaging, nutrigenomics, molecular neurobiology, pharmacology, neurogenetics, and clinical trials. A number of abstracts involve genome-wide DNA methylation mapping and gene expression including histone replacement, messenger RNA interference (miRNA) as well any other epigenetic studies.
The first day of the conference started with keynote lecture by Dr. Kenneth Blum, University of Florida, on Genetic Addiction in Reward Deficiency Syndrome: Synaptamine Complex Variant (Kb220z) Induced "Dopamine Sensitivity" and it followed by Dr. David E. Smith, Co-founder of American Society of Addiction Medicine (ASAM) and founder of the "free clinic movement" in the world, keynote speech on Process Addictions and Addiction Transfer. The Day 1 was highlighted with the talk of some of the highly eloquent speakers and well know scientists working on Dopamine and Addiction medicine and Substance Abuse treatment. Dopamine function in obesity presented by Dr. Panayotis K. Thanos, important topics from legalization of marijuana presented by Dr. Peter Banys and a Keynote from Dr. John J. Giordano concerning his recovery from drugs and alcohol and his development of a holistic approach to addiction treatment and Dr. David Baron keynote on sports medicine and addiction liability are the other
